We are proud to announce that an ARCC funded study led by Dr. Sonya Cressman and published in The Oncologist has been selected as a CME offering. Their article titled: “A time-trend economic analysis of cancer drug trials” is available for a Maximum of 1 credit unit course.
The target audience for this is Physicians who wish to advance their current knowledge of economics and oncology practice.
This course hopes to develop your ability to:
- Explain the challenges associated with modern drug funding and resource allocation decisions in cancer.
- Describe the need for better economic evidence to support uptake of the most promising drugs.
- Discuss the public health perspective on drug value.
The credit course is available now until July 9th 2017.
To download a copy of this article CLICK HERE.
To begin this credit course CLICK HERE.
For more Oncology-related CME credit courses CLICK HERE.